✦ LIBER ✦

Attention abnormalities in chronic hepatitis c (CHC) patients during peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may persist after treatment discontinuation

✍ Scribed by Pawelczyk, T.; Strzelecki, D.; Pawelczyk, A.; Rabe-Jablonska, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

peg-interferon alpha and ribavirin (peg-

✍ Pawelczyk, T.; Strzelecki, D.; Pawelczyk, A.; Rabe-Jablonska, J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 40 KB

P.3.15 Peg-interferon alpha and ribaviri

✍ A. Pawelczyk; T. Pawelczyk; J. Rabe-Jablonska 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P.5.a.002 Peg-interferon alpha and ribav

✍ T. Pawelczyk; A. Pawelczyk; D. Strzelecki; J. Bialkowska; M. Jablkowski; D. Dwor 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Tongue and Skin Hyperpigmentation During

✍ Gurguta, Calin; Kauer, Clemens; Bergholz, Ulrike; Formann, Elisabeth; Steindl-Mu 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB

Immune alterations and profile of lympho

✍ Guilherme Macedo; Susana Lopes; Joao Pedro Ramos; Fernando Araujo; Fernando Tava 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 26 KB

Pegylated interferon alpha-2b (Peg-IFN α

✍ T. Oze; N. Hiramatsu; T. Yakushijin; M. Kurokawa; T. Igura; K. Mochizuki; K. Ima 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB